Rhumbline Advisers raised its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 70.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 138,477 shares of the company's stock after acquiring an additional 57,443 shares during the quarter. Rhumbline Advisers owned approximately 0.28% of Nu Skin Enterprises worth $954,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in NUS. Creative Planning increased its holdings in Nu Skin Enterprises by 43.0% during the 3rd quarter. Creative Planning now owns 41,226 shares of the company's stock valued at $304,000 after acquiring an additional 12,398 shares in the last quarter. Covestor Ltd increased its holdings in Nu Skin Enterprises by 110.9% during the 3rd quarter. Covestor Ltd now owns 10,140 shares of the company's stock valued at $75,000 after acquiring an additional 5,333 shares in the last quarter. Versor Investments LP purchased a new position in Nu Skin Enterprises during the 3rd quarter valued at about $86,000. Aigen Investment Management LP purchased a new position in Nu Skin Enterprises during the 3rd quarter valued at about $111,000. Finally, Gladius Capital Management LP purchased a new stake in shares of Nu Skin Enterprises during the third quarter worth about $77,000. 82.84% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages have recently commented on NUS. DA Davidson lowered their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating for the company in a report on Friday, December 20th. StockNews.com upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a report on Tuesday, February 25th.
View Our Latest Research Report on NUS
Nu Skin Enterprises Trading Down 1.0 %
Shares of NYSE NUS traded down $0.08 during midday trading on Friday, reaching $7.96. 547,281 shares of the stock were exchanged, compared to its average volume of 794,097. The company has a market capitalization of $395.65 million, a P/E ratio of -2.70 and a beta of 1.06. Nu Skin Enterprises, Inc. has a 52-week low of $5.95 and a 52-week high of $14.04. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56. The stock has a 50 day moving average price of $7.09 and a 200-day moving average price of $7.18.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The firm had revenue of $445.55 million during the quarter, compared to the consensus estimate of $441.10 million. Equities research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were issued a $0.06 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a yield of 3.02%. Nu Skin Enterprises's payout ratio is -8.14%.
About Nu Skin Enterprises
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.